eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers; Availability
Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers; Availability
Document ID:
FDA-2013-D-0446-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2013-11005
CFR Citation:
21 CFR Part 312
View Document:
Details Information
Document Subtype:
Notice of Availability
Received Date:
May 09 2013, at 12:00 AM Eastern Daylight Time
Start-End Page:
27115 - 27116
Page Count:
2
Comment Start Date:
May 9 2013, at 12:00 AM Eastern Standard Time
Comment Due Date:
July 8 2013, at 11:59 PM Eastern Standard Time
Comments
Total:
0
No comments posted.
Related Documents
Total:
3
Draft Guidance for Industry on Charging for Investigational Drugs Under an Investigational New Drug Application-Questions and Answers; Availability
Draft Guidance for Industry; Availability: Charging for Investigational Drugs Under an Investigational New Drug Application-Questions and Answers
Draft Guidance for Industry; Availability: Expanded Access to Investigational Drugs for Treatment Use-Questions and Answers
Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers; Availability
Details Information
Comments
Related Documents